Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...

A 54-year-old patient’s routine mammogram finds a 6-mm breast nodule that histology confirms as kidney cancer metastasis, 3 ...

New AI technology can spot breast cancer in MRI scans more accurately than current digital methods, while also pinpointing ...

Cassandra and Katelyn Harding suffered the loss of their mother before both being diagnosed with rare osteosarcoma ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

A new documentary shines light on battling breast cancer. "One in Eight" shares the journey of 10 women living in and around ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.

Celcuity’s stock jumps after Phase 3 trial shows gedatolisib slashes progression risk in breast cancer patients by up to 76%.

Breast cancer rates among women are on the rise, and doctors are pointing to alcohol as a potential contributing factor.

Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer in a late-stage study, sending the biotech firm's shares surging to a record ...